semaglutide/tirzepatide weight loss Medical 🔥 Semaglutide vs Tirzepatide: What's

For example, nausea affects up to 44% of patients on the highest dose of semaglutide (Wegovy), though rates are typically lower at starting doses

Cardiovascular Outcomes Trial of Semaglutide in Patients with Type 2 Diabetes Mellitus SUSTAIN 6 (NCT01720446) was a 104-week, double-blind trial in which 3,297 patients with type 2 diabetes and high risk of cardiovascular events were randomized to semaglutide 0.5 mg once weekly, semaglutide 1 mg once weekly, or placebo in addition to standard-of-care

Yoo C, Xing D, Gonzalez DE, Jenkins V, Nottingham K, Dickerson B, et al

we feel you

If TSH has dropped below target or below normal range, discuss levothyroxine dose reduction with your prescriber